# E1-R5 Forward Readiness R3 — Shadow Validation Status

Status: **RESEARCH / SHADOW ONLY**  
Production activation: **NO**  
Production baseline: **E1-R4 remains active**

## Purpose

Read the already-stored E1-R5 SEC cross-filing evidence, CFO Survey PIT releases, and SEC historical backfill ledger and report what is actually ready for the approved future-outlook block.

This diagnostic does **not** change the approved formula, weights, normalization, missing policy, storage schema, scheduler, DB/D1 state, or Production wiring.

Approved raw inputs remain:

- S12A Management EPS Guidance Revision Magnitude: 4%
- S12B CFO Forward Revenue Outlook Revision: 3%
- S13 Management Guidance Breadth: 3%

Approved composition remains:

`S12 = (4*S12A + 3*S12B) / 7`

`D = (7*S12 + 3*S13) / 10`

Missing components are not reweighted.

## What R3 evaluates

R3 reports:

1. SEC current/history hash-integrity state.
2. S12A/S13 comparable-pair coverage across the full issuer set and among issuers with current parsed guidance.
3. Current S12A, S12B, and S13 **raw** values.
4. The number of usable CFO Survey periods and consecutive quarterly revision observations.
5. The local storage window of the historical SEC backfill.
6. The seven required Shadow validation gates from `EARNINGS_E1_R5_FORWARD_R2.md`.

## Important interpretation

A complete retrospective SEC backfill does not by itself create historical local PIT observations.

The cross-filing contract preserves `storedAt <= asOf`. Therefore, SEC documents fetched retrospectively can support current research and source-integrity checks, but they cannot be silently treated as if they had been locally stored at older historical evaluation timestamps.

For that reason R3 leaves historical-percentile normalization and Production composition null until sufficient PIT history exists.

R3 also does not invent a minimum acceptable comparable-pair coverage threshold. It reports both:

- comparable issuers / all current issuers; and
- comparable issuers / issuers with current parsed guidance.

## Required evidence still pending before Production

- manual sample review of target-period / basis / unit matching accuracy;
- multi-period S12A and S13 series for Spearman analysis;
- multi-period S12B series aligned with S1/S2/S6 and Growth;
- next-1Q / next-2Q earnings, revenue, margin and EPS-breadth outcomes;
- true PIT history sufficient for historical-percentile normalization and PIT-only backtesting.

Until these are satisfied, `productionReady=false` and E1-R4 remains the Production baseline.
